ReviewCurrent hematologic malignancy reports2019

Trends in Clinical Benefits and Costs of Novel Therapeutics in AML: at What Price Does Progress Come?

Jennifer E Vaughn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.